KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Capital Expenditures (2016 - 2025)

Astrana Health (ASTH) has disclosed Capital Expenditures for 15 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 21.06% to $3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Dec 2025, up 25.84% year-over-year, with the annual reading at $10.1 million for FY2025, 25.84% up from the prior year.
  • Capital Expenditures hit $3.1 million in Q4 2025 for Astrana Health, up from $2.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $22.9 million in Q4 2022 to a low of -$18.8 million in Q3 2022.
  • Historically, Capital Expenditures has averaged $4.4 million across 5 years, with a median of $2.9 million in 2024.
  • Biggest YoY gain for Capital Expenditures was 17745.92% in 2022; the steepest drop was 308.09% in 2022.
  • Year by year, Capital Expenditures stood at $2.8 million in 2021, then soared by 718.41% to $22.9 million in 2022, then tumbled by 69.24% to $7.1 million in 2023, then tumbled by 64.13% to $2.5 million in 2024, then increased by 21.06% to $3.1 million in 2025.
  • Business Quant data shows Capital Expenditures for ASTH at $3.1 million in Q4 2025, $2.6 million in Q3 2025, and $1.4 million in Q2 2025.